https://www.selleckchem.com/pr....oducts/acalabrutinib
4 min, P = .003), cardiac arrest time (75.5 ± 21.2 versus 95.7 ± 56.4 min, P .001), SCP time (100.8 ± 25.5 versus 124 ± 23.2 min, P .001), lower body circulation arrest time (17.2 ± 4.2 versus 62.5 ± 19.3 min, P .001) were significantly shorter in the endo-balloon occlusion group. There were no perioperative neurological and renal complications or mortality in FET group. The new technique enabled a decrease in mechanical ventilation time (8.6 ± 1.4 versus 13.9 ± 5.7 min, P = .015) and hospital length of stay (9.7 ±
Curtir
Comentario
Compartilhar
